Indirect comparisons of ranibizumab and dexamethasone in macular oedema secondary to retinal vein occlusion

被引：0
|
作者：
Howard HZ Thom
Gorana Capkun
Richard M Nixon
Alberto Ferreira
机构：
[1] University of Bristol,School of Social and Community Medicine
[2] Novartis Pharma,undefined
来源：
BMC Medical Research Methodology | / 14卷
关键词：
Ranibizumab; Dexamethasone; Retinal vein occlusion; Central retinal vein occlusion; Branch retinal vein occlusion; Macular oedema; Evidence synthesis; Indirect comparison;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population
    Gu, Xiaoya
    Yu, Xiaobing
    Song, Shuang
    Dai, Hong
    OPHTHALMIC RESEARCH, 2017, 58 (01) : 8 - 14
  • [42] Macular microcirculation and macular oedema in branch retinal vein occlusion
    Noma, H.
    Funatsu, H.
    Sakata, K.
    Harino, S.
    Nagaoka, T.
    Mimura, T.
    Sone, T.
    Hori, S.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (05) : 630 - 633
  • [43] Comparison of Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab as a First-Line Treatment of Macular Oedema due to Retinal Vein Occlusion
    Mayer, W. J.
    Hadjigoli, A.
    Wolf, A.
    Herold, T.
    Haritoglou, C.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2015, 232 (11) : 1289 - 1296
  • [44] Comparison of ranibizumab versus dexamethasone for macular oedema following retinal vein occlusion: 1-year results of the COMRADE extension study
    Feltgen, Nicolas
    Hattenbach, Lars-Olof
    Bertelmann, Thomas
    Callizo, Josep
    Rehak, Matus
    Wolf, Armin
    Berk, Huesnue
    Eter, Nicole
    Lang, Gabriele E.
    Pielen, Amelie
    Schmitz-Valckenberg, Steffen
    Quiering, Claudia
    Rose, Uwe
    Hoerauf, Hans
    ACTA OPHTHALMOLOGICA, 2018, 96 (08) : E933 - E941
  • [45] Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
    Vasileios E. Konidaris
    Konstantinos T. Tsaousis
    Rossella Anzidei
    Guillermo de la Mata
    Alexander J. Brent
    Ophthalmology and Therapy, 2018, 7 : 387 - 395
  • [46] Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
    Konidaris, Vasileios E.
    Tsaousis, Konstantinos T.
    Anzidei, Rossella
    de la Mata, Guillermo
    Brent, Alexander J.
    OPHTHALMOLOGY AND THERAPY, 2018, 7 (02) : 387 - 395
  • [47] The efficacy and safety of intravitreal dexamethasone implants for macular oedema secondary to retinal vein occlusion: 3-year experience
    Higham, Aisling
    Jacob, Sarita
    Cox, Miriam
    Baker, Catherine
    Al-Husainy, Sahar
    Sivaraj, Ramesh
    Gibson, Jonathan M.
    ACTA OPHTHALMOLOGICA, 2016, 94 (07) : E674 - E675
  • [48] Perifoveal Microcirculation in Macular Oedema with Retinal Vein Occlusion
    Noma, Hidetaka
    Funatsu, Hideharu
    Mimura, Tatsuya
    Shimada, Katsunori
    OPEN OPHTHALMOLOGY JOURNAL, 2012, 6 : 63 - 64
  • [49] Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion
    Li, Fengjiao
    Sun, Ming
    Guo, Jianlian
    Ma, Aihua
    Zhao, Bojun
    CURRENT EYE RESEARCH, 2017, 42 (08) : 1174 - 1178
  • [50] Comparison of intravitreal ranibizumab and bevacizumab for the treatment of macular edema secondary to retinal vein occlusion
    Alex Yuan
    Baseer U.Ahmad
    David Xu
    Rishi P.Singh
    Peter K.Kaiser
    Daniel F.Martin
    Jonathan E.Sears
    Andrew P.Schachat
    Justis P.Ehlers
    International Journal of Ophthalmology, 2014, 7 (01) : 86 - 91
12345